Quest Diagnostics Inc. (DGX) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic path...
Quest Diagnostics Inc. (DGX) currently trades at a P/E ratio of 26.76 (historical range: 19.56–26.83, median: 21.50), placing it at the 99th percentile — expensive relative to its history, P/S ratio of 2.43 (range: 1.72–2.44, 99th percentile — expensive relative to its history), EV/EBITDA of 80.62 (range: 15.69–80.79, 99th percentile).
Quest Diagnostics Inc. appears overvalued relative to its own historical valuation range, trading at elevated multiples across most metrics.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 26.76 | 19.56 | 21.50 | 26.83 | 99th | expensive relative to its history |
| P/S Ratio | 2.43 | 1.72 | 1.93 | 2.44 | 99th | expensive relative to its history |
| EV/EBITDA | 80.62 | 15.69 | 30.18 | 80.79 | 99th | expensive relative to its history |
| FCF Yield | 0.01 | 0.01 | 0.03 | 0.07 | 0th | expensive relative to its history |